Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01070290Phase 2Withdrawn
A Phase 2 trial of tivantinib in gastric cancer (GC). Status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01070290.